Diabetic Retinopathy Market Analysis by Size, Share, Growth, Trends
  • Reads 1
  • Votes 0
  • Parts 1
  • Time <5 mins
  • Reads 1
  • Votes 0
  • Parts 1
  • Time <5 mins
Ongoing, First published Apr 09
The diabetic retinopathy market is expected to grow at a compound annual growth rate (CAGR) of 9.1% to reach $24,614.83 million in 2030, according to a new report by UnivDatos Market Insights. Diabetic retinopathy is a complication of diabetes that affects the eyes. This occurs when high blood sugar levels damage blood vessels in the retina, the light-sensitive tissue at the back of the eye. There are two main types of diabetic retinopathy.

1. Nonproliferative diabetic retinopathy (NPDR): In this early stage, small blood vessels in the retina leak fluid or blood, forming deposits called edema or exudate. Vision may become slightly blurred, but serious vision problems are less common at this stage.

2. Proliferative diabetic retinopathy (PDR): In advanced stages, new abnormal blood vessels grow on the surface of the retina. These fragile blood vessels can leak blood into the eye, causing severe vision loss or even blindness. PDR can also form scar tissue, causing the retina to separate from the back of the eye.

Request to download a sample of this Strategy Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=56397
All Rights Reserved
Sign up to add Diabetic Retinopathy Market Analysis by Size, Share, Growth, Trends to your library and receive updates
or
#1retinopathy
Content Guidelines
You may also like
Slide 1 of 1
Lorem_Ipsum_Wp Take 14 cover

Lorem_Ipsum_Wp Take 14

3 parts Ongoing

Just another test story